Margherita Corbo

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma

Andrew Webb, David Cunningham, Finbarr E. Cotter et al. · The Lancet · 1997 · 498 citations

Medicine, Cancer Biology, Oncology +13

Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species

Dean A. Fennell, Margherita Corbo, A. Pallaska et al. · British Journal of Cancer · 2001 · 71 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

The Kinetics and Extent of Engraftment of Chronic Myelogenous Leukemia Cells in Non-Obese Diabetic/Severe Combined Immunodeficiency Mice Reflect the Phase of the Donor’s Disease: An In Vivo Model of Chronic Myelogenous Leukemia Biology

Francesco Dazzi, Debora Capelli, Robert P. Hasserjian et al. · Blood · 1998 · 69 citations

Life Sciences, Hematology, Immunology +12

<i>In vivo</i> suppression of Bcl‐X_L expression facilitates chemotherapy‐induced leukaemia cell death in a SCID/NOD‐Hu model

Dean A. Fennell, Margherita Corbo, Nicholas M. Dean et al. · British Journal of Haematology · 2001 · 43 citations

Medicine, Oncology, Pharmacology +12

<i>In vitro</i> and <i>in vivo</i> downregulation of MRP1 by antisense oligonucleotides: A potential role in neuroblastoma therapy

Bryone J. Kuss, Margherita Corbo, Wen Min Lau et al. · International Journal of Cancer · 2001 · 28 citations

Medicine, Oncology, Pharmacology +11